相似文献
1
Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial.
Circ Heart Fail. 2013 Sep 1;6(5):1087-94. doi: 10.1161/CIRCHEARTFAILURE.113.000347.
2
Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).
Circ Heart Fail. 2016 Aug;9(8). doi: 10.1161/CIRCHEARTFAILURE.115.002593.
3
History of Atrial Fibrillation and Trajectory of Decongestion in Acute Heart Failure.
JACC Heart Fail. 2019 Jan;7(1):47-55. doi: 10.1016/j.jchf.2018.09.008. Epub 2018 Nov 5.
4
Acute decompensated heart failure: the shrinking role of inotropic therapy.
J Am Coll Cardiol. 2005 Jul 5;46(1):65-7. doi: 10.1016/j.jacc.2005.04.007.
5
Is there still a role for low-dose dopamine use in acute heart failure?
Curr Opin Crit Care. 2014 Oct;20(5):467-71. doi: 10.1097/MCC.0000000000000133.
6
Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin.
Clin Res Cardiol. 2015 Aug;104(8):621-31. doi: 10.1007/s00392-015-0839-y. Epub 2015 Mar 19.
7
ROSE-AHF and lessons learned.
Curr Heart Fail Rep. 2014 Sep;11(3):260-5. doi: 10.1007/s11897-014-0208-6.
8
Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF.
Clin Res Cardiol. 2016 Sep;105(9):727-37. doi: 10.1007/s00392-016-0979-8. Epub 2016 Mar 26.
9
Decongestive therapy and renal function in acute heart failure: time for a new approach?
Circ Heart Fail. 2014 May;7(3):531-5. doi: 10.1161/CIRCHEARTFAILURE.113.000828.
10
Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence.
Cardiovasc Ther. 2017 Feb;35(1):55-63. doi: 10.1111/1755-5922.12231.
引用本文的文献
1
The Early Pharmacological Strategy with Inodilator, bEta-blockers, Mineralocorticoid Receptor Antagonists, Sodium-glucose coTransporter-2 Inhibitors and Angiotensin Receptor-neprylisin Inhibitors in Acute Heart Failure (PENTA-HF).
Curr Vasc Pharmacol. 2025;23(3):213-223. doi: 10.2174/0115701611334141241217044516.
2
Improvement in Renal Function During the Treatment of Acute Decompensated Heart Failure: Relationship With Markers of Renal Tubular Injury and Prognostic Importance.
Circ Heart Fail. 2023 Mar;16(3):e009776. doi: 10.1161/CIRCHEARTFAILURE.122.009776. Epub 2023 Jan 26.
3
The interstitial compartment as a therapeutic target in heart failure.
Front Cardiovasc Med. 2022 Aug 17;9:933384. doi: 10.3389/fcvm.2022.933384. eCollection 2022.
4
Pharmacological interventions for heart failure in people with chronic kidney disease.
Cochrane Database Syst Rev. 2020 Feb 27;2(2):CD012466. doi: 10.1002/14651858.CD012466.pub2.
5
Natriuretic Response Is Highly Variable and Associated With 6-Month Survival: Insights From the ROSE-AHF Trial.
JACC Heart Fail. 2019 May;7(5):383-391. doi: 10.1016/j.jchf.2019.01.007.
6
Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network).
Am J Cardiol. 2017 Jul 1;120(1):98-105. doi: 10.1016/j.amjcard.2017.03.249. Epub 2017 Apr 12.
7
Implications of Using Different Definitions on Outcomes in Worsening Heart Failure.
Circ Heart Fail. 2016 Aug;9(8). doi: 10.1161/CIRCHEARTFAILURE.116.003048.
8
Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure).
Circ Heart Fail. 2016 Aug;9(8). doi: 10.1161/CIRCHEARTFAILURE.115.002593.
9
Biomarkers of acute kidney injury and associations with short- and long-term outcomes.
F1000Res. 2016 May 24;5. doi: 10.12688/f1000research.7998.1. eCollection 2016.
10
Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials.
J Card Fail. 2016 Nov;22(11):875-883. doi: 10.1016/j.cardfail.2016.04.014. Epub 2016 Apr 28.
本文引用的文献
1
Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure).
J Am Coll Cardiol. 2013 Sep 24;62(13):1177-83. doi: 10.1016/j.jacc.2013.04.073. Epub 2013 Jun 7.
2
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.
Circ Heart Fail. 2013 May;6(3):606-19. doi: 10.1161/HHF.0b013e318291329a. Epub 2013 Apr 24.
3
Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
J Am Coll Cardiol. 2013 Jan 15;61(2):196-206. doi: 10.1016/j.jacc.2012.11.005.
4
Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.
Circ Heart Fail. 2013 Mar;6(2):240-5. doi: 10.1161/CIRCHEARTFAILURE.112.969246. Epub 2012 Dec 18.
5
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.
Circulation. 2013 Jan 1;127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad. Epub 2012 Dec 12.
6
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
Lancet. 2013 Jan 5;381(9860):29-39. doi: 10.1016/S0140-6736(12)61855-8. Epub 2012 Nov 7.
7
Ultrafiltration in decompensated heart failure with cardiorenal syndrome.
N Engl J Med. 2012 Dec 13;367(24):2296-304. doi: 10.1056/NEJMoa1210357. Epub 2012 Nov 6.
8
Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure.
J Am Coll Cardiol. 2012 Sep 18;60(12):1031-42. doi: 10.1016/j.jacc.2012.01.077. Epub 2012 Jul 25.
9
The worst symptom as defined by patients during heart failure hospitalization: implications for response to therapy.
J Card Fail. 2012 Jul;18(7):524-33. doi: 10.1016/j.cardfail.2012.04.012. Epub 2012 May 30.
10
Prognostic implications of renal dysfunction in patients hospitalized with heart failure: data from the last decade of clinical investigations.
Heart Fail Rev. 2013 Mar;18(2):167-76. doi: 10.1007/s10741-012-9317-z.
Zotero 插件